Using the common terminology criteria for adverse events (CTCAE – Version 5.0) to evaluate the severity of adverse events of anticancer therapies - Freites-Martinez, A; Santana, N; Arias-Santiago, S (Actas Dermosifiliogr (Engl Ed), 2021)
et al.